{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670318332641024.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/mt.2012.83"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1525001616321608?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1525001616321608?httpAccept=text/xml"}}],"dc:title":[{"@value":"Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670318332641037","@type":"Researcher","foaf:name":[{"@value":"Omar D Perez"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641033","@type":"Researcher","foaf:name":[{"@value":"Christopher R Logg"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641030","@type":"Researcher","foaf:name":[{"@value":"Kei Hiraoka"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641039","@type":"Researcher","foaf:name":[{"@value":"Oscar Diago"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641024","@type":"Researcher","foaf:name":[{"@value":"Ryan Burnett"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641025","@type":"Researcher","foaf:name":[{"@value":"Akihito Inagaki"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641026","@type":"Researcher","foaf:name":[{"@value":"Dawn Jolson"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641027","@type":"Researcher","foaf:name":[{"@value":"Karin Amundson"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641035","@type":"Researcher","foaf:name":[{"@value":"Taylor Buckley"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641031","@type":"Researcher","foaf:name":[{"@value":"Dan Lohse"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641038","@type":"Researcher","foaf:name":[{"@value":"Amy Lin"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641028","@type":"Researcher","foaf:name":[{"@value":"Cindy Burrascano"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641029","@type":"Researcher","foaf:name":[{"@value":"Carlos Ibanez"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641034","@type":"Researcher","foaf:name":[{"@value":"Noriyuki Kasahara"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641036","@type":"Researcher","foaf:name":[{"@value":"Harry E Gruber"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318332641032","@type":"Researcher","foaf:name":[{"@value":"Douglas J Jolly"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"15250016"}],"prism:publicationName":[{"@value":"Molecular Therapy"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2012-09","prism:volume":"20","prism:number":"9","prism:startingPage":"1689","prism:endingPage":"1698"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","http://creativecommons.org/licenses/by-nc-nd/4.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1525001616321608?httpAccept=text/plain"},{"@id":"https://api.elsevier.com/content/article/PII:S1525001616321608?httpAccept=text/xml"}],"createdAt":"2012-05-01","modifiedAt":"2024-12-18","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360021390585080064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283692586107264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708438844416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565167562817920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567179832669568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Biotransporting Self‐Assembled Nanofactories Using Polymer Vesicles with Molecular Permeability for Enzyme Prodrug Cancer Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183415557120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183415569024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dual-vector prodrug activator gene therapy using retroviral replicating vectors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849940841473664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Recent progress in the research of suicide gene therapy for malignant glioma"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/mt.2012.83"},{"@type":"CROSSREF","@value":"10.3390/ijms241914823_references_DOI_CN5QIB0eF2kSv6xLlHA34QGp2Wu"},{"@type":"CROSSREF","@value":"10.1093/neuonc/nox038_references_DOI_CN5QIB0eF2kSv6xLlHA34QGp2Wu"},{"@type":"CROSSREF","@value":"10.1038/s41417-018-0020-7_references_DOI_CN5QIB0eF2kSv6xLlHA34QGp2Wu"},{"@type":"CROSSREF","@value":"10.1093/neuonc/nox037_references_DOI_CN5QIB0eF2kSv6xLlHA34QGp2Wu"},{"@type":"CROSSREF","@value":"10.1002/adma.201702406_references_DOI_CN5QIB0eF2kSv6xLlHA34QGp2Wu"},{"@type":"CROSSREF","@value":"10.1038/s41417-018-0037-y_references_DOI_CN5QIB0eF2kSv6xLlHA34QGp2Wu"},{"@type":"CROSSREF","@value":"10.1038/s41417-018-0051-0_references_DOI_CN5QIB0eF2kSv6xLlHA34QGp2Wu"},{"@type":"CROSSREF","@value":"10.1007/s10143-019-01203-3_references_DOI_CN5QIB0eF2kSv6xLlHA34QGp2Wu"}]}